Modulation of melatonin secretion in cancer patients: Possible mechanisms and significance for prognosis, diagnosis and treatment

Frontiers of Hormone Research

Volumn 23, Issue , 1997, Pages 115-124

  Bartsch, Christian ^a   Bartsch, H ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0344591894     PISSN: 03013073     EISSN: None     Source Type: Book Series    
DOI: 10.1159/000060989     Document Type: Review

References (34)

1. Lapin V: Pineal gland and malignancy. Öster Z Onkol 1976;3:51-60.
2. Blask DE: The pineal: An oncostatic gland? in Reiter RJ (ed): The Pineal Gland. New York, Raven, 1984, pp 253-284.
3. Relkin R: The pineal and human disease; in Relkin R (ed): Annual Research Reviews. Hornby, Lundsdale House, 1976, vol 1: The Pineal, pp 76-79.
4. Bartsch C, Bartsch H, Flüchter St H, Mecke D, Lippert TH: Diminished pineal function coincides with disturbed circadian endocrine rhythmicity in untreated primary cancer patients. Ann NY Acad Sci 1994;719:502-525.
5. Bartsch H, Bartsch C, Mecke D, Lippert TH: Serial transplants of DMBA-induced mammary tumours in Fischer rats as model system for human breast cancer. I: Effect of melatonin and pineal extracts on slow- and fast-growing passages - In vivo and in vitro studies. Adv Pineal Res 1994:8:473-478.
6. Bartsch H, Bartsch C: Effect of melatonin on experimental tumors under different photoperiods and times of administration. J Neural Transm 1981;52:269-279.
7. Bartsch C, Bartsch H, Laumas KR, Wetterberg L: Urinary melatonin levels in human breast cancer patients. J Neural Transm 1981;52:281-294.
8. Bartsch C, Bartsch H, Fuchs U, Lippert TH, Bellmann O, Gupta D: Stage-dependent depression of melatonin in patients with primary breast cancer. Cancer 1989:64:426-433.
9. Tamarkin L, Danforth D, Lichter A, Demoss E, Cohen M, Chabner B, Lippman M: Decreased nocturnal plasma melatonin peak in patients with estrogen receptor positive breast cancer. Science 1982;216:1003-1005.
10. Karasek M, Dec W, Kowalski AJ. Bartsch H, Bartsch C: Serum melatonin circadian profile in women with adenocarcinoma of uterine corpus. Int J Thymol, in press.
11. Bartsch C, Bartsch H, Flüchter St H, Attanasio A, Gupta D: Evidence for modulation of melatonin secretion in men with benign and malignant tumors of the prostate: Relationship with the pituitary hormones. J Pineal Res 1985;2:121-132.
12. Bartsch C, Bartsch H, Flüchter St H, Attanasio A, Gupta D: Melatonin rhythms in prostate cancer patients: Effect of operation and hormone treatment. J Neural Transm 1985;21(suppl):491.
13. Wetterberg L, Halberg F, Tarquini B, Cagnoni M, Haus E, Griffith K, Kawasaki T, Wallach LA, Ueno M, Uezo K, Matsuoka M, Kuzel M, Halberg E, Omae T: Circadian variation in urinary melatonin in clinically healthy women in Japan and the United States of America. Experientia 1979;35:416-418.
14. Khoory R, Stemme D: Plasma melatonin levels in patients suffering from colorectal carcinoma. J Pineal Res 1988;5:251-258.
15. Bartsch C, Bartsch H, Bellmann O, Lippert TH: Depression of serum melatonin in patients with primary breast cancer is not due to an increased peripheral metabolism. Cancer 1991;67:1681-1684.
16. Bartsch C, Bartsch H, Schmidt A, Ilg S, Bichler KH, Flüchter St H: Melatonin and 6-sulphatoxymelatonin circadian rhythms in serum and urine of primary prostate cancer patients: Evidence for reduced pineal activity and relevance of urinary determinations. Clin Chim Acta 1992;209:153-167.
17. Bartsch C, Bartsch H, Gupta D: Pineal melatonin synthesis and secretion during induction and growth of mammary cancer in female rats; in Gupta D, Wollmann HA, Ranke MB (eds): Neuroendocrinology: New Frontiers. London; Brain Research Promotion, 1990, pp 325-332.
18. Bartsch C, Bartsch H, Buchberger A, Rokos H, Mecke D, Lippert TH: Serial transplants of DMBA-induced mammary tumors in Fischer rats as model system for human breast cancer. IV: Parallel changes of biopterin and melatonin indicate interactions between the pineal gland and cellular immunity in malignancy. Oncology 1995;52:278-283.
19. Bartsch C, Bartsch H, Buchberger A, Stieglitz A, Mecke D, Lippert TH: Serial transplants of DMBA-induced mammary tumours in Fischer rats as model system for human breast cancer. II: Analysis of pineal melatonin biosynthesis and secretion. Adv Pineal Res 1994;8:479-484.
20. Bartsch C, Bartsch H: The modulation of pineal melatonin secretion in malignancy: Results and possible mechanisms; in Webb S, Puig-Domingo M (eds): Pineal Gland Update: 1996. From Molecular Mechanisms to Clinical Implications. Weslbury, PJD Electronic, in press.
21. Curzon G: The control of tryptophan metabolism. Basic Life Sci 1975;6:169-184.
22. Blask DE: Potential sites of action of pineal hormones within the neuroendocrine reproductive axis; in Reiter RJ (ed): The Pineal Gland. Boca Raton, CRC, vol 2: Reproductive Effects, 1981, pp 189-216.
23. Harper ME, Peeling WB, Cowley T, Brownsey BG, Philips MEA, Groom G, Fahmy DR, Griffith K: Plasma steroid and protein hormone concentrations in patients with prostatic carcinoma, before and during oestrogen therapy. Acta Endocrinol (Copenh) 1976;81:409-426.
24. Arendt J: Melatonin. Clin Endocrinol 1988;29:205-229.
25. Touitou Y, Bogdan A, Claustrat B, Touitou C: Drugs affecting melatonin secretion in man; in Trentini GP, DeGaetani C, Pévet P (eds): Fundamentals and Clinics in Pineal Research. New York, Raven, 1987, pp 349-356.
26. Wrba H, Halberg F, Dutter A: Melatonin circadian-stage dependently delays breast cancer development in mice injected daily for several months. Chronobiologia 1986;13:123-128.
27. Maestroni GJM: The immunoneuroendocrine role of melatonin. J Pineal Res 1993;14:1-10.
28. Hill SM, Blask DE: Effects of the pineal hormone melatonin on the proliferation and morphological characteristics of human breast cancer cells (MCF-7) in culture. Cancer Res 1988;48:6121-6126.
29. L'Hermitc-Balériaux M, deLauniot Y: Is melatonin really an in vitro inhibitor of human breast cancer cell proliferation? In Vitro Cell Dev Biol 1992;28:583-584.
30. Shellard SA, Whelan RDH, Hill BT: Growth inhibitory and cytotoxic effects of melatonin and its metabolites on human tumour cell lines in vitro. Br J Cancer 1989;60:288-290.
31. Bartsch H, Bartsch C, Simon WE, Flehmig B, Ebels I, Lippert TH: Antitumor activity of the pineal gland: Effect of unidentified substances versus the effect of melatonin. Oncology 1992;49:27-30.
32. Conli A, Maestroni GJM: The clinical neuroimmunotherapeutic role of melatonin in oncology. J Pineal Res 1995;19:103-110.
33. Subramanian A, Kolhari L: Melatonin, a suppressor of spontaneous murine mammary tumors. J Pineal Res 1991;10:136-140.
34. Cohen M, Small RA, Brzezinski A: Hypotheses: Melatonin/steroid combination contraceptives will prevent breast cancer. Breast Cancer Res Treat 1995;33:257-264.